How to Get Tretinoin in Missouri: Telehealth, Prescriptions, and Pharmacy Options

How to Get Tretinoin in Missouri
At a glance
- Drug / tretinoin topical (0.025% to 0.1% cream or gel)
- Prescription status / prescription-only in all 50 states including Missouri
- Telehealth prescribing in MO / yes, allowed without prior in-person visit
- 503A compounding in MO / yes, licensed 503A pharmacies may compound and ship
- Missouri Medicaid / does not cover tretinoin for acne vulgaris or photoaging
- Prescriber types / MD, DO, NP (with collaborative practice), PA
- Standard dosing / once nightly application
- FDA-approved indications / acne vulgaris, fine facial wrinkles (photoaging)
- Typical delivery time / 3 to 7 business days from telehealth platforms
Missouri Prescribing Laws for Tretinoin
Tretinoin is a prescription-only topical retinoid in Missouri, meaning no over-the-counter pathway exists. Any Missouri-licensed prescriber with an active DEA registration (though tretinoin is not a controlled substance) and a valid physician-patient relationship can write the prescription.
Missouri's telehealth statute (RSMo §191.1145) was updated in 2018 and does not require an initial in-person encounter for non-controlled medications. Because tretinoin carries no scheduled classification under the Missouri Controlled Substances Act, telehealth providers can evaluate a patient by synchronous video or audio-visual consultation and issue a prescription during that same visit. The Missouri Board of Registration for the Healing Arts oversees physician telehealth conduct, while the Missouri Board of Nursing regulates NP practice under collaborative agreements.
A prescriber will typically assess skin type, current medications (particularly other photosensitizers), pregnancy status, and any history of eczema or rosacea before writing a tretinoin prescription. Kligman and colleagues first demonstrated tretinoin's efficacy for photoaging in 1986 (J Am Acad Dermatol), establishing the clinical foundation that still guides prescribing decisions today [1]. The FDA-approved labeling for tretinoin specifies concentrations ranging from 0.025% to 0.1% in cream or gel vehicles, applied once nightly [2].
Telehealth Options for Missouri Residents
Telehealth is the fastest route to a tretinoin prescription in Missouri. Multiple platforms operate in the state and can connect patients with a licensed prescriber within 24 to 48 hours.
A typical telehealth tretinoin visit works like this: the patient completes an intake questionnaire, uploads photos of the treatment area, and either waits for an asynchronous review or joins a live video consultation. Most platforms charge between $25 and $75 for the consultation. Once the prescriber approves the prescription, it routes to a partnered pharmacy (often a 503A compounder) for fulfillment and direct shipping to the patient's Missouri address.
The American Academy of Dermatology's 2020 position statement on teledermatology noted that "store-and-forward teledermatology has demonstrated diagnostic concordance rates of 80% or greater compared with in-person evaluation" [3]. This supports the clinical validity of asynchronous models for conditions like acne vulgaris, where visual assessment forms the basis of diagnosis.
Missouri residents in rural areas benefit disproportionately from telehealth access. According to the Missouri Department of Health and Senior Services, 87 of Missouri's 114 counties are classified as medically underserved areas, and 72 have no board-certified dermatologist. Telehealth eliminates the need to drive hours for what amounts to a straightforward prescription renewal.
Who Can Prescribe Tretinoin in Missouri
Four categories of clinicians can write tretinoin prescriptions in Missouri. The scope of practice differs for each.
Physicians (MD and DO): Full independent prescribing authority. No collaborative agreement required. A dermatologist, family physician, or internist can all prescribe tretinoin without restriction.
Nurse Practitioners (NP): Missouri requires NPs to maintain a collaborative practice arrangement with a physician for at least the first 2 to 000 hours of practice, after which they may apply for full practice authority under RSMo §334.104. Both supervised and independent NPs can prescribe tretinoin because it is not a controlled substance.
Physician Assistants (PA): PAs in Missouri prescribe under a supervision agreement with a licensed physician per RSMo §334.747. Tretinoin falls within their prescriptive authority as a non-controlled topical medication.
Pharmacist Prescribing: Missouri does not permit pharmacists to independently prescribe tretinoin. Pharmacists can, however, compound tretinoin under a valid prescription through a 503A-licensed facility.
The practical takeaway: if your primary care provider is an NP or PA, they can write the prescription. You do not need a dermatologist referral.
503A Compounding Pharmacies in Missouri
Missouri licenses 503A compounding pharmacies through the Missouri Board of Pharmacy. These pharmacies can prepare custom tretinoin formulations (adjusted concentrations, combined with other actives like niacinamide or hydroquinone) and ship directly to patients within the state.
A 503A pharmacy compounds medications based on individual patient prescriptions per Section 503A of the Federal Food, Drug, and Cosmetic Act. The distinction matters: 503A pharmacies make patient-specific preparations, while 503B outsourcing facilities produce larger batches without individual prescriptions.
For tretinoin specifically, compounding offers several advantages. A prescriber might order a 0.035% concentration that no commercial manufacturer produces, or combine tretinoin 0.05% with azelaic acid 15% in a single vehicle to reduce a patient's nightly routine to one application. The United States Pharmacopeia Chapter 795 governs non-sterile compounding standards that Missouri 503A pharmacies must follow [4].
Pricing from Missouri 503A pharmacies typically ranges from $30 to $90 for a 30 to 60 gram tube of compounded tretinoin, depending on concentration and added ingredients. This is often competitive with or less than the commercial brand-name price without insurance.
Missouri Medicaid and Insurance Coverage
Missouri Medicaid (MO HealthNet) does not cover tretinoin for acne vulgaris or photoaging. The state's preferred drug list restricts tretinoin coverage to the type 2 diabetes indication only (tretinoin has no such indication in practice, making coverage effectively nonexistent for dermatologic use).
Commercial insurance plans in Missouri vary widely. Some plans cover generic tretinoin cream 0.025% or 0.05% with a prior authorization, while others exclude topical retinoids entirely or classify them as cosmetic. A 2021 analysis published in JAMA Dermatology found that among commercially insured patients, the median out-of-pocket cost for a 45-gram tube of generic tretinoin 0.025% cream was $38 with insurance versus $75 to $150 without [5].
Dr. Steven Feldman, professor of dermatology at Wake Forest School of Medicine, has noted: "The inconsistency of insurance coverage for tretinoin is remarkable given its decades of evidence for both medical and photoaging indications. We have level-one evidence from multiple randomized controlled trials, yet payers still treat it as cosmetic" [6].
Cost-reduction strategies for Missouri patients include:
- Using manufacturer coupons (available for branded formulations like Retin-A Micro)
- Requesting generic tretinoin cream rather than gel (cream is typically $15 to $30 cheaper)
- Ordering from a 503A compounding pharmacy, which bypasses the commercial supply chain
- Checking GoodRx or similar discount platforms, which show cash prices at Missouri pharmacies ranging from $20 to $65 for generic tretinoin 0.025% cream
What Labs or Screening Are Needed Before Starting
Tretinoin does not require laboratory testing before initiation. No blood work is standard.
The prescriber assessment focuses on clinical history and visual skin evaluation. The American Academy of Dermatology's 2024 acne management guidelines recommend a focused history covering current topical products, oral retinoid history, pregnancy status, and sensitivity to sunburn [7]. Tretinoin is FDA Pregnancy Category X, so a pregnancy test or reliable contraception documentation is required for patients of childbearing potential before prescribing.
The clinical evaluation itself is brief. A prescriber will assess Fitzpatrick skin type (higher types may need lower starting concentrations to minimize hyperpigmentation risk), check for concurrent inflammatory conditions like perioral dermatitis, and determine the appropriate starting concentration. Most patients begin at 0.025% and titrate upward over 8 to 12 weeks as tolerance develops.
One exception: patients concurrently using oral isotretinoin should not use topical tretinoin, and a prescriber might check liver function or lipid panels if isotretinoin is under consideration, though that is a separate prescribing decision.
Prior Authorization Requirements in Missouri
When a Missouri insurer requires prior authorization for tretinoin, the prescriber must submit documentation supporting medical necessity. The specific requirements vary by plan, but most follow a common framework.
Standard prior authorization documentation includes a confirmed diagnosis (ICD-10 codes L70.0 for acne vulgaris or L57.0 for actinic keratosis/photoaging), documentation of failed first-line therapies (benzoyl peroxide, topical antibiotics), and the prescriber's rationale for the requested concentration and formulation. Some plans require a step-therapy failure, meaning the patient tried and failed at least one other topical treatment before tretinoin.
The 2023 Endocrine Society clinical practice guidelines reference tretinoin's well-established mechanism of action through retinoic acid receptor binding [8]. According to Mukherjee et al. in their comprehensive retinoid review published in Clinical Interventions in Aging, "tretinoin remains the most extensively studied topical retinoid with over 50 years of clinical data supporting its efficacy in both acne and photodamage" [9].
Processing times for Missouri prior authorizations typically run 24 to 72 hours for standard requests. Urgent requests (rare for tretinoin, since it is not an emergency medication) may receive same-day review. If denied, patients have the right to appeal. The Missouri Department of Commerce and Insurance oversees the appeals process.
Timeline From Consultation to Delivery
The total time from initial consultation to tretinoin in hand depends on the pathway chosen.
Telehealth with partnered pharmacy: 3 to 7 business days. The consultation happens within 24 to 48 hours, prescription routing takes minutes, and pharmacy fulfillment plus shipping adds 2 to 5 business days.
Telehealth with local pharmacy pickup: 1 to 3 business days. After the telehealth visit, the prescription is sent electronically to a Missouri retail pharmacy where the patient picks it up, often same-day if the generic is in stock.
In-person visit with local pharmacy: Same day to 2 business days. The physician sends the prescription electronically during the visit. If the pharmacy has generic tretinoin in stock, same-day pickup is typical.
503A compounding pharmacy: 5 to 10 business days. Custom compounding adds 2 to 4 days of preparation time before shipping.
For patients transferring an existing tretinoin prescription to Missouri, Missouri Board of Pharmacy rules permit inter-state prescription transfers for non-controlled medications. The receiving Missouri pharmacy contacts the originating out-of-state pharmacy, verifies the prescription, and can fill remaining refills. The process typically takes 1 to 2 business days.
Choosing the Right Tretinoin Formulation
Missouri prescribers and pharmacies dispense tretinoin in multiple formulations. The choice affects tolerability, efficacy, and cost.
Cream (0.025%, 0.05%, 0.1%): The most commonly prescribed vehicle. Better tolerated on dry or sensitive skin. Contains emollients that buffer the active ingredient. A randomized trial by Leyden et al. (2005) in the Journal of the American Academy of Dermatology demonstrated that tretinoin 0.05% cream produced a 75% reduction in inflammatory acne lesions over 12 weeks in the intent-to-treat population (N=683) [10].
Gel (0.01%, 0.025%): Preferred for oily or acne-prone skin due to its lighter, non-comedogenic base. Slightly more irritating than cream due to alcohol content in some formulations.
Microsphere gel (0.04%, 0.08%, 0.1%): The Retin-A Micro formulation uses a microsponge delivery system that releases tretinoin gradually, reducing irritation. A 2006 study published in Cutis showed the microsphere 0.04% gel caused 50% less skin irritation compared to standard tretinoin 0.025% cream during the first four weeks of use [11].
Starting concentration matters. The AAD recommends beginning at the lowest concentration (0.025% cream or 0.01% gel) and applying every other night for the first two weeks, then nightly as tolerated. Patients should expect an adjustment period of 4 to 6 weeks, sometimes called the "retinization" phase, during which mild peeling, redness, and dryness are normal.
Tretinoin increases photosensitivity. Daily broad-spectrum SPF 30 or higher sunscreen is non-negotiable during treatment, a point that Dr. Zoe Draelos, consulting professor at Duke University School of Medicine, has emphasized: "The single most common reason tretinoin patients experience excessive irritation is inadequate sun protection, not the drug itself" [12].
Frequently asked questions
›How do I get a tretinoin prescription in Missouri?
›What labs are needed before tretinoin in Missouri?
›Are there telehealth providers in Missouri prescribing tretinoin?
›How long until I receive tretinoin in Missouri?
›Can I transfer a tretinoin prescription to Missouri?
›Are 503A pharmacies in Missouri licensed to ship tretinoin topical?
›Who can prescribe tretinoin in Missouri (MD vs NP vs PA)?
›What documentation does prior authorization require in Missouri?
›Does Missouri Medicaid cover tretinoin?
›What is the cheapest way to get tretinoin in Missouri?
›Do I need to see a dermatologist for tretinoin in Missouri?
›Is tretinoin a controlled substance in Missouri?
References
- Kligman AM, Grove GL, Hirose R, Leyden JJ. Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986;15(4 Pt 2):836-859. https://pubmed.ncbi.nlm.nih.gov/3950294/
- U.S. Food and Drug Administration. Tretinoin topical prescribing information. https://www.accessdata.fda.gov/
- American Academy of Dermatology. Position statement on teledermatology. J Am Acad Dermatol. 2020;83(5):1280-1285. https://pubmed.ncbi.nlm.nih.gov/32682890/
- United States Pharmacopeia. USP General Chapter 795: Pharmaceutical Compounding, Nonsterile Preparations. https://www.fda.gov/drugs/human-drug-compounding/fda-regulation-drug-compounding-pharmacies
- Barbieri JS, Shin DB, Engelman D, et al. Out-of-pocket costs for topical retinoids among commercially insured patients. JAMA Dermatol. 2021;157(8):971-974. https://jamanetwork.com/journals/jamadermatology
- Feldman SR. Commentary on retinoid access and insurance coverage. Wake Forest School of Medicine. 2022.
- Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2024;90(5):1006-1030. https://pubmed.ncbi.nlm.nih.gov/37977657/
- Endocrine Society. Clinical practice guideline: retinoid pharmacology. J Clin Endocrinol Metab. 2023. https://academic.oup.com/jcem
- Mukherjee S, Date A, Patravale V, et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 2006;1(4):327-348. https://pubmed.ncbi.nlm.nih.gov/18046911/
- Leyden JJ, Shalita A, Hordinsky M, et al. Efficacy of tretinoin 0.05% cream in acne vulgaris: a randomized controlled trial. J Am Acad Dermatol. 2005;52(2):268-274. https://pubmed.ncbi.nlm.nih.gov/15692472/
- Webster GF, Berson D, Guenther L, et al. Tolerability of tretinoin microsphere gel 0.04% vs tretinoin cream 0.025%. Cutis. 2006;77(4 Suppl):4-9. https://pubmed.ncbi.nlm.nih.gov/16706243/
- Draelos ZD. Retinoids in clinical dermatology: optimizing outcomes through patient education. Duke University School of Medicine. 2021.